Skip to main content

5-Gene-Multiplex cfDNA (AF: 1.0%)

Gene targets: AKT1, BRAF, ERBB2, KRAS, PIK3CA

AF: 1.0%

The selected genes and mutations are diagnostically and therapeutically of high relevance and also play a role in various tumour entities such as:

Breast Carcinoma,  Colorectal Carcinoma,  Melanoma, Non-Small Cell Lung Carcinoma,  Small Cell Lung Carcinoma,  Prostate Carcinoma,  Lymphoma,  Head and Neck Carcinoma,  Hepatocellular Carcinoma,  Multiple Myeloma,  Pancreatic Adenocarcinoma,  Ovarian Carcinoma,  Bladder Carcinoma, Bile Duct Carcinoma and others.

The 5-Gene-Multiplex 1.0% AF cfDNA product can be used as a positive standard in liquid biopsy assays in your R&D department, as well as for validation and development of AKT1, BRAF, KRAS, ERBB2 or PIK3CA diagnostic kits. Background material is highly characterized human cfDNA from cell lines.

 

How to create your full workflow plasma control material based on this product:

We recommend the use of our human DNA-free plasma products to produce complete workflow controls with this product. Blend the cfDNA as necessary with the DNA depleted plasma to receive plasma materials with the necessary DNA concentrations.

These products are ideal for digital PCR and/or Next Generation Sequencing (NGS). In particular:
– Validation and development of sequencing protocols (e.g. Whole Genome Sequencing (WGS), Amplicon Sequencing) and PCR protocols
– Determination of the detection limit of the method

Unit Size:
400 ng

Concentration:
20 ng/µl

Mutations:

  • AKT1 – p.E17K (COSV62571334*, Substitution, c.49G>A)
  • BRAF – p.V600E (COSV56056643*, Substitution, c.1799T>A)
  • ERBB2 – p.Y772_A775dup (COSV54062409*, Insertion, c.2313_2324dup)
  • KRAS – p.G12D (COSV55497369*, Substitution, c.35G>A)
  • KRAS – p.Q61K (COSV55502066*, Substitution, c.181C>A)
  • KRAS – p.A146T (COSV55501778*, Substitution, c.436G>A)
  • PIK3CA – p.E545K (COSV55873239*, Substitution, c.1633G>A)
  • PIK3CA – p.H1047R (COSV55873195*, Substitution, c.3140A>G)

Allele frequency:

1.0%

Buffer:
Tris-EDTA (10 mM Tris, 1 mM EDTA), pH 8.0

Storage:
2-8 °C

Expiration:
stable for 24 months from date of manufacture (as supplied)

Quality control

Fragmentation size:
Elektrophoresis-Bioanalyzer-High Sensitivity DNA Kit Agilent

Allele Frequency / copies (metrologically traceable):
dPCR

Quantification (metrologically traceable):

  1. UV-Vis Spectrophotometry (NIST-Reference method) measurement of total DNA
  2. fluorometric dsDNA measurement

Technical background

Derived from:
cell line GM24385 (HG002- NA24385 – huAA53E0)

*GRCh 38 Cosmic v90

 

 

Specifications

  • Quantity: 1
  • Product Code: SID-000093

Related Products

  • Plasma 2x Human Tech, DNA Free

    Plasma 2x Human Tech, DNA Free

    "Plasma 2x (human-tech) DNA free" is human recreated DNA free plasma.

    It contains all relevant components of human plasma after blood draw and plasma separation: Human serum proteins in common plasma concentrations, Electrolytes and EDTA.

    EDTA concentration in all plasma products complies with the recommendations of ICSH (International Council Society of Haematology) and the CLSI (Clinical and Laboratory Standards Institute) for EDTA in blood collection tubes.

     

  • Plasma 1x Human Tech, DNA Free (40ml)

    Plasma 1x Human Tech, DNA Free (40ml)

    "Plasma 1x (human-tech) DNA free" is human recreated DNA free plasma.

    It contains all relevant components of human plasma after blood draw and plasma separation: Human serum proteins in common plasma concentrations, Electrolytes and EDTA.

    EDTA concentration in all plasma products complies with the recommendations of ICSH (International Council Society of Haematology) and the CLSI (Clinical and Laboratory Standards Institute) for EDTA in blood collection tubes.

     

  • Plasma 1x Human Tech, DNA Free (1 litre)

    Plasma 1x Human Tech, DNA Free (1 litre)

    "Plasma 1x (human-tech) DNA free" is human recreated DNA free plasma.

    It contains all relevant components of human plasma after blood draw and plasma separation: Human serum proteins in common plasma concentrations, Electrolytes and EDTA.

    EDTA concentration in all plasma products complies with the recommendations of ICSH (International Council Society of Haematology) and the CLSI (Clinical and Laboratory Standards Institute) for EDTA in blood collection tubes.